Latest period
112.00M
YoY change
0.0%
5Y CAGR
-3.6%
Peak year (2003)
216.20M
Latest annual
113.00M
Shares Outstanding history chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: 113.00M
Shares Outstanding growth chart for Quest Diagnostics (DGX) from 1996 to 2025
Latest: 0.0%
Shares Outstanding history table for Quest Diagnostics (DGX) from 1996 to 2025
| 2025 | 113.00M | 0.0% | 0 | ||
| 2024 | 113.00M | 0.0% | 0 | ||
| 2023 | 113.00M | -4.2% | -5.00M | ||
| 2022 | 118.00M | -7.8% | -10.00M | ||
| 2021 | 128.00M | -5.9% | -8.00M | ||
| 2020 | 136.00M | 0.0% | 0 | ||
| 2019 | 136.00M | -2.2% | -3.00M | ||
| 2018 | 139.00M | -0.7% | -1.00M | ||
| 2017 | 140.00M | -1.4% | -2.00M | ||
| 2016 | 142.00M | -2.1% | -3.00M | ||
| 2015 | 145.00M | 0.0% | 0 | ||
| 2014 | 145.00M | -5.2% | -8.00M | ||
| 2013 | 153.00M | -4.4% | -7.10M | ||
| 2012 | 160.10M | -0.1% | -100,000 | ||
| 2011 | 160.20M | -9.6% | -17.10M | ||
| 2010 | 177.30M | -5.6% | -10.50M | ||
| 2009 | 187.80M | -4.2% | -8.20M | ||
| 2008 | 196.00M | +0.4% | +738,000 | ||
| 2007 | 195.26M | -2.1% | -4.28M | ||
| 2006 | 199.54M | -2.9% | -5.99M | ||
| 2005 | 205.53M | -3.2% | -6.89M | ||
| 2004 | 212.42M | -1.7% | -3.77M | ||
| 2003 | 216.20M | +8.4% | +16.72M | ||
| 2002 | 199.48M | +2.0% | +3.93M | ||
| 2001 | 195.55M | +3.5% | +6.56M | ||
| 2000 | 188.99M | +39.0% | +52.99M | ||
| 1999 | 136.00M | +12.5% | +15.10M | ||
| 1998 | 120.90M | +4.1% | +4.75M | ||
| 1997 | 116.15M | -1.1% | -1.30M | ||
| 1996 | 117.45M | — | — |
- 2025113.00M0.0%
- 2024113.00M0.0%
- 2023113.00M-4.2%
- 2022118.00M-7.8%
- 2021128.00M-5.9%
- 2020136.00M0.0%
- 2019136.00M-2.2%
- 2018139.00M-0.7%
- 2017140.00M-1.4%
- 2016142.00M-2.1%
- 2015145.00M0.0%
- 2014145.00M-5.2%
- 2013153.00M-4.4%
- 2012160.10M-0.1%
- 2011160.20M-9.6%
- 2010177.30M-5.6%
- 2009187.80M-4.2%
- 2008196.00M+0.4%
- 2007195.26M-2.1%
- 2006199.54M-2.9%
- 2005205.53M-3.2%
- 2004212.42M-1.7%
- 2003216.20M+8.4%
- 2002199.48M+2.0%
- 2001195.55M+3.5%
- 2000188.99M+39.0%
- 1999136.00M+12.5%
- 1998120.90M+4.1%
- 1997116.15M-1.1%
- 1996117.45M—
Shares Outstanding values are taken from Quest Diagnostics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Shares Outstanding at Quest Diagnostics (DGX)
According to Quest Diagnostics's latest reported financial statements, the company's latest reported diluted shares outstanding is 112.00M. Diluted weighted-average shares outstanding is the share count used to compute per-share metrics like EPS. Buybacks lower it; new issuance, stock-based compensation, and convertible securities raise it. Multiply by the stock price for market capitalization.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2025, Quest Diagnostics (DGX) diluted shares outstanding totalled 113.00M – edged up 0.0% year-over-year.
Over 2020–2025 (5 years), Quest Diagnostics diluted shares outstanding expanded at a -3.6% compound annual rate, with a net decline across the window.
Between 2003 and 2025, Quest Diagnostics diluted shares outstanding plunged 47.7%, falling from 216.20M to 113.00M.
Across the available history, diluted shares outstanding reached its high of 216.20M in 2003 and its low of 113.00M in 2023.
Quest Diagnostics Shares Outstanding by Year
Quest Diagnostics Shares Outstanding 2025: 113.00M
Quest Diagnostics diluted shares outstanding in 2025 was 113.00M, edged up 0.0% from 2024.
Quest Diagnostics Shares Outstanding 2024: 113.00M
2024's diluted shares outstanding for Quest Diagnostics came in at 113.00M, edged up 0.0% from 2023.
Quest Diagnostics Shares Outstanding 2023: 113.00M
Quest Diagnostics posted diluted shares outstanding of 113.00M in 2023, edged down 4.2% below 2022. This figure represents the lowest annual value in the available history.
Quest Diagnostics Shares Outstanding 2022: 118.00M
In 2022, Quest Diagnostics reported diluted shares outstanding of 118.00M, declined 7.8% below 2021.
Quest Diagnostics Shares Outstanding 2021: 128.00M
Quest Diagnostics diluted shares outstanding in 2021 was 128.00M.
See more financial history for Quest Diagnostics (DGX).
Sector peers by Shares Outstanding
Healthcare peers of Quest Diagnostics (DGX), ranked by their latest diluted shares outstanding
| 4.45B | |
| 2.51B | |
| 2.43B | |
| 1.77B | |
| 1.56B | |
| 910.00M | |
| 898.00M | |
| 542.00M |
- 4.45B
- 2.51B
- 1.77B
- 1.56B
- 910.00M
- 898.00M
- 542.00M
Frequently asked questions
Quest Diagnostics (DGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation